Carregant...
The Current and Emerging Role of Immunotherapy in Prostate Cancer
Recent phase III trial results have demonstrated the effectiveness of sipuleucel-T, a therapeutic cancer vaccine, in the treatment of metastatic prostate cancer. Yet despite the survival benefit of sipuleucel-T, questions remain about how immunologic agents can be employed in the treatment of metast...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3447981/ https://ncbi.nlm.nih.gov/pubmed/21208850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CGC.2010.n.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|